Harnessing a natural plant insecticide for commercial use
Many plants produce molecules or peptides that help them combat destructive insects. These natural insecticides hold a lot of promise for improving how we can protect crops around the world from pests without harming the environment
Developing plant insecticides into eco-friendly products is one area of interest in David Craik’s laboratory, which is part of the Institute for ͵͵ Bioscience at the University of Queensland, Brisbane, Queensland, Australia.
Craik’s lab identified a group of cyclotides in a prior study and found that they have natural insecticidal properties. Cyclotides are unique; unlike typical peptides that form linear chains of amino acids, cyclotides link together end to end to form circular peptides. These cyclopeptides can interact with specific phospholipids that form cell membranes. This can happen within the insect’s gut and cause cell swelling or lysis that results in death or growth restriction of the insect. The Craik lab has become interested in studying the applications of these cyclotides, particularly as potential pesticides.
In their , conducted in collaboration with Syngenta Crop Protection AG, an international agriculture technology company, and published in the Journal of Biological Chemistry, Craik’s lab focused on a specific cyclotide known as kalata B1. For an insecticide to have broad use, a business must be able to manufacture it efficiently and cost-effectively. It must also remain stable in a variety of environmental conditions where factors such as temperature and pH may differ considerably.
To address these issues, the Craik lab mutated specific amino acids within the cyclotide to determine their impact on the molecule's stability under varying conditions. This was achieved through a technique called a lysine scan, where each amino acid within the cyclotide was systematically replaced with lysine. The researchers then evaluated whether the change enhanced the stability of the cyclopeptide.
This work enabled the lab to create a more stable cyclopeptide capable of targeting insect cells from the fall armyworm, a major pest worldwide. They also confirmed that they could manufacture this cyclopeptide efficiently and safely.
“We can actually use a natural recombinant process to produce these proteins,” Craik said. “Some types of peptide synthesis can be quite an environmentally unfriendly process in terms of the amount of waste materials produced. But if you can produce peptides, and then cyclize them using enzymes rather than chemicals, you have a much greater production pathway.”
As of now, the only other cyclotide insecticide on the market is one known as . Approved for use in Australia, it is applied to cotton plants and certain vegetable crops.
The next step for the Craik lab is to feed the cyclotide insecticide to fall armyworms and determine if it is effective in killing them. If these trials prove successful, another cyclotide insecticide may soon be available for use.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Quantifying how proteins in microbe and host interact
“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
CRISPR gene editing: Moving closer to home
With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.
Finding a missing piece for neurodegenerative disease research
Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.
From the journals: JLR
Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.